Volume 21, Issue 6, Pages (June 2014)

Slides:



Advertisements
Similar presentations
Volume 13, Issue 10, Pages (October 2006)
Advertisements

Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Volume 18, Issue 2, Pages (February 2010)
Structural Basis for the Highly Selective Inhibition of MMP-13
Volume 21, Issue 2, Pages (February 2014)
Volume 14, Issue 3, Pages (March 2006)
Volume 11, Issue 3, Pages (March 2007)
Ping Wang, Katelyn A. Doxtader, Yunsun Nam  Molecular Cell 
Volume 20, Issue 6, Pages (June 2013)
Volume 21, Issue 3, Pages (March 2014)
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
Volume 22, Issue 7, Pages (July 2014)
Volume 16, Issue 1, Pages (January 2008)
Volume 21, Issue 2, Pages (February 2014)
Volume 14, Issue 1, Pages (April 2004)
The Molecular Basis of Aichi Virus 3A Protein Activation of Phosphatidylinositol 4 Kinase IIIβ, PI4KB, through ACBD3  Jacob A. McPhail, Erik H. Ottosen,
Volume 14, Issue 12, Pages (December 2006)
Crystal Structures of a Ligand-free and Malonate-Bound Human Caspase-1
Volume 21, Issue 9, Pages (September 2013)
Xiaojing He, Yi-Chun Kuo, Tyler J. Rosche, Xuewu Zhang  Structure 
Volume 21, Issue 6, Pages (March 2006)
Shane J. Caldwell, Yue Huang, Albert M. Berghuis  Structure 
Volume 36, Issue 4, Pages (November 2009)
Volume 14, Issue 5, Pages (May 2007)
Volume 18, Issue 2, Pages (February 2010)
Volume 13, Issue 10, Pages (October 2006)
Joseph D. Mancias, Jonathan Goldberg  Molecular Cell 
Choel Kim, Cecilia Y. Cheng, S. Adrian Saldanha, Susan S. Taylor  Cell 
Substrate Recognition Mechanism of Atypical Protein Kinase Cs Revealed by the Structure of PKCι in Complex with a Substrate Peptide from Par-3  Chihao.
Nadine Keller, Jiří Mareš, Oliver Zerbe, Markus G. Grütter  Structure 
Crystal Structure of an Inactive Akt2 Kinase Domain
Volume 21, Issue 5, Pages (May 2014)
Volume 26, Issue 1, Pages e5 (January 2019)
Ins and Outs of Kinase DFG Motifs
Hybrid Structure of the RagA/C-Ragulator mTORC1 Activation Complex
Volume 9, Issue 6, Pages (June 2002)
Volume 21, Issue 11, Pages (November 2013)
Volume 20, Issue 10, Pages (October 2012)
A Subdomain Swap Strategy for Reengineering Nonribosomal Peptides
Volume 16, Issue 5, Pages (May 2009)
Structural Analysis of Ligand Stimulation of the Histidine Kinase NarX
Volume 16, Issue 4, Pages (April 2008)
Volume 22, Issue 12, Pages (December 2014)
Volume 14, Issue 5, Pages (May 2006)
Jiao Yang, Melesse Nune, Yinong Zong, Lei Zhou, Qinglian Liu  Structure 
Volume 21, Issue 2, Pages (February 2014)
Volume 19, Issue 9, Pages (September 2011)
Volume 42, Issue 1, Pages 9-22 (April 2011)
Volume 3, Issue 5, Pages (May 1999)
Volume 16, Issue 12, Pages (September 2016)
Structural Basis for the Highly Selective Inhibition of MMP-13
Molecular Basis of Drug Resistance in Aurora Kinases
Volume 25, Issue 6, Pages e6 (June 2017)
Volume 23, Issue 6, Pages (June 2015)
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases  Sanjay B.
Volume 18, Issue 11, Pages (November 2011)
E.Radzio Andzelm, J Lew, S Taylor  Structure 
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
The Structure of JNK3 in Complex with Small Molecule Inhibitors
Volume 27, Issue 5, Pages (September 2007)
Volume 15, Issue 6, Pages (June 2008)
Three protein kinase structures define a common motif
Basis of Mutual Domain Inhibition in a Bacterial Response Regulator
Volume 19, Issue 2, Pages (February 2012)
Volume 22, Issue 11, Pages (November 2015)
Peter Man-Un Ung, Rayees Rahman, Avner Schlessinger 
Volume 25, Issue 4, Pages e4 (April 2018)
Volume 21, Issue 6, Pages (June 2013)
Volume 21, Issue 6, Pages (June 2013)
Volume 23, Issue 10, Pages (October 2016)
Presentation transcript:

Volume 21, Issue 6, Pages 754-765 (June 2014) Molecular Mechanism of Regulation of the Atypical Protein Kinase C by N-terminal Domains and an Allosteric Small Compound  Hua Zhang, Sonja Neimanis, Laura A. Lopez-Garcia, José M. Arencibia, Sabine Amon, Adriana Stroba, Stefan Zeuzem, Ewgen Proschak, Holger Stark, Angelika F. Bauer, Katrien Busschots, Thomas J.D. Jørgensen, Matthias Engel, Jörg O. Schulze, Ricardo M. Biondi  Chemistry & Biology  Volume 21, Issue 6, Pages 754-765 (June 2014) DOI: 10.1016/j.chembiol.2014.04.007 Copyright © 2014 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2014 21, 754-765DOI: (10. 1016/j. chembiol. 2014 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 The Domain Structure of PKC Isoforms and the Atypical PKC Constructs Used in This Study (A) The structure of the catalytic domain of PKCι (PDB code 3A8W) (Takimura et al., 2010). The PIF-pocket, indicated by a box, is the physiological binding site of the C-terminal HM. Phe residues of the HM are represented as red sticks. (B) A schematic overview of the PKC isoforms indicates the different domains present in the classical, novel, and atypical PKCs (C2, C2 domain; C1, C1 domain; PB1, PB1 domain; Cat. Domain, protein kinase catalytic domain) and the full-length and truncated constructs of atypical PKCs used in this study. PKMζ corresponds to a splicing variant of PKCζ that lacks all N-terminal regulatory domains. The equivalent regulatory domains within the different PKC isoforms are the PSRs and their contiguous C1 domains (C1A domains in classical and novel PKCs). Chemistry & Biology 2014 21, 754-765DOI: (10.1016/j.chembiol.2014.04.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 Deuterium Incorporation Levels of PKCι Δ223 and PKCι 1–587 The proteins were incubated in deuterated buffer, and the exchange of hydrogen (1H) for deuterium (2H) was analyzed by mass spectrometry after protease cleavage. We identified polypeptides covering 81% of the isolated catalytic domain of PKCι (Figure S3). A subset of polypeptides was protected from 1H/2H exchange in full-length PKCι (PKCι 1–587) in comparison with the isolated catalytic domain (PKCι Δ223). (A) The catalytic domain of PKCι (PDB code 3A8W), indicating the location of polypeptides that were protected from 1H/2H exchange mainly in two distinct regions (boxed). Region 1 encompasses amino acid sequences from the αC and αE helix and the DFG motif (DYG in PKCι) located at the interphase between the small and large lobe. Region 2 encompasses sequences from the P+1 loop and part of helix αF located on the large lobe. (B–N) Deuterium incorporation exchange at 10, 100, 1,000, and 10,000 s in the indicated peptides derived from PKCι Δ223 (closed circles) and PKCι 1–587 (open circles). Chemistry & Biology 2014 21, 754-765DOI: (10.1016/j.chembiol.2014.04.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 3 Deuterium Incorporation Levels of PKCι Δ223 in the Presence and Absence of PSRtide PKCι Δ223 was incubated in deuterated buffer in the presence and absence of PSRtide, a synthetic peptide derived from the pseudosubstrate region of PKCζ, and the exchange of hydrogen (1H) for deuterium (2H) was analyzed by mass spectrometry after protease cleavage. We identified polypeptides covering 81% of the isolated catalytic domain of PKCι. Some polypeptides were protected from 1H/2H exchange upon treatment of the PSRtide. (A) Catalytic domain of PKCι (PDB code 3A8W), indicating the location of polypeptides that were protected from 1H/2H exchange. (B–N) Deuterium incorporation at 1, 100, 1,000,and 10,000 s in the indicated peptides from PKCι Δ223 incubated in the absence (closed circles) and presence (open circles) of PSRtide. Chemistry & Biology 2014 21, 754-765DOI: (10.1016/j.chembiol.2014.04.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 4 Effects of Ligands on Thermal Stability and Kinase Activity of PDK1 and PKCι The thermal stability of PKCι Δ223, PKCι 1–587, dmPDK1, and dmPDK1-ζ in the absence and presence of ligand was assessed by differential scanning fluorimetry (see also Figure S4). For each kinase, the midpoint temperature of transition was calculated in the absence (T0) or presence (Tm) of ligand. The presented shift in thermal stability (ΔTm = Tm − T0) of the proteins is the average of two experiments. The kinase activity of PDK1 and PKCι was measured in vitro using T308tide or MBP as a substrate. Data are presented as means ± SEM. (A) Effect of 100 μM PSRtide or 20 μM staurosporine on the thermal stability of full-length PKCι (PKCι 1–587) or its catalytic domain (PKCι Δ223). (B) Effect of 75 μM PS314 and PS315 on the thermal stability of PKCι Δ223, PKCι 1–587, dmPDK1, and dmPDK1-ζ and effect of 400 μM PS48 on the thermal stability of dmPDK1 and dmPDK1-ζ. (C) Chemical structures of PS compounds. (D) Effect of 100 μM PS315 on the kinase activity of PKCι Δ223, PKCι 1–587, PKCζ Δ241, PKCζ 1–592, dmPDK1, and dmPDK1-ζ. (E) Inhibition of PKCζ and PKCι by PS315. (F) Effect of 100 μM PS48 on the kinase activity of dmPDK1 and dmPDK1-ζ and effect of 100 μM PS168 on the kinase activity of dmPDK1-ζ. Chemistry & Biology 2014 21, 754-765DOI: (10.1016/j.chembiol.2014.04.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 5 Binding Modes of the Allosteric Compounds PS315 in dmPDK1-ζ and PS48 in dmPDK1 (A) Cartoon representation of the PIF-pocket in the crystal structure of dmPDK1 (Hindie et al., 2009) (PDB code 3HRC). The eight residues mutated to mimic the PIF-pocket of PKCζ are highlighted as purple sticks. The introduced residues are shown as pink sticks. (B) PIF-pocket of PS48-bound dmPDK1. The allosteric compound PS48 is depicted in yellow. Interacting residues are shown as sticks. (C) PIF-pocket of the dmPDK1-ζ (pink) binding compound PS315 (represented as beige sticks). Important residues are depicted as sticks. The mutation of Phe157 (purple) to Leu opens up a tunnel to the active site of the kinase. (D) Cut through a surface representation of dmPDK1 (carbon atoms in gray, nitrogen in blue, oxygen in red). PS48 and ATP are shown as sticks in their respective binding pockets. (E) Cut through the small lobe of PS315-bound dmPDK1-ζ, showing the tunnel between the PIF-pocket and ATP-binding site. The |2FO−FC| electron density map of PS315 is contoured at 1σ. (F) Superimposition of the structures of PS48-bound dmPDK1 (purple) and PS315-bound dmPDK1-ζ (pink) with focus on the interface between the active site and the tunnel to the PIF-pocket. Compound PS315 causes the ε−amino group of Lys111 to be unresolved and to lose its salt bridges with Glu130 and the α-phosphate of ATP. Furthermore, conformational changes of Ser92 and Phe93 in the Gly-rich loop were observed. Chemistry & Biology 2014 21, 754-765DOI: (10.1016/j.chembiol.2014.04.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 6 Effect of PS315 on the Activity of PKCι Δ223 ΔHM and on the Interaction with the PSR-C1 Domains (A) Regulation of the kinase activity of PKCι by PS315. The kinase activity of PKCι Δ223 and PKCι Δ223 ΔHM was measured in vitro using MBP as a substrate. The kinase activity of PKCι Δ223 ΔHM missing the C-terminal region, including the HM, was more strongly inhibited by PS315 than by PKCι Δ223. (B) Interaction of the isolated PSR-C1 domain of PKCι with its catalytic domain. The AlphaScreen interaction assay shows the binding of 18 nM GST-PSR-C1 (PKCι 100–185) to 25 nM His-PKCι Δ223. This interaction was strongly diminished upon addition of PS315. In contrast, PS314 was not able to displace the interaction. Data are presented as means ± SEM (∗∗p < 0.01; ∗∗∗p < 0.001). Chemistry & Biology 2014 21, 754-765DOI: (10.1016/j.chembiol.2014.04.007) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 7 Graphic Model of aPKC Regulation by N-terminal Domains and Allosteric Inhibition by PS315 (A) The structural models of the different domains of an active aPKC are shown as a surface representation. The C-terminal region (red) comprising the HM in the active structure of aPKCs is not required for activity and may be in equilibrium between unbound and bound to the PIF-pocket. 1H/2H exchange experiments suggest that the helix αC is flexible in the active structure of the catalytic domain. (B) 1H/2H exchange experiments confirm that the PSR binds at the peptide-substrate binding site and suggest that the contiguous C1 domain interacts with helix αC, protecting it from 1H/2H exchange. In this manner, the PIF-pocket appears as a key feature of the allosteric inhibition of aPKCs by N-terminal domains. In the full-length protein, the C-terminal region is protected from 1H/2H exchange. The mechanism of this protection is not clear. The PSR not only participates in the inhibition of the activity, but it is also required for the activation by phospholipids (Lopez-Garcia et al., 2011). (C) PS315 inhibits aPKC by occupying the PIF-pocket and by allosterically affecting the key residue Lys111 at the active site. PS315 binds similarly as the previously described PS48 but, in addition, occupies a deep tunnel behind helix αC that is absent in the structure of active kinases. PS315 binding displaces the C-terminal HM from the PIF-pocket and also allosterically disrupts the interaction between the PSR-C1 domains and the catalytic domain. Chemistry & Biology 2014 21, 754-765DOI: (10.1016/j.chembiol.2014.04.007) Copyright © 2014 Elsevier Ltd Terms and Conditions